Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022

Author of the article: Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022 Mont-Saint-Guibert, Belgium – July 19, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive…
Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022

Author of the article:

Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022

Mont-Saint-Guibert, Belgium – July 19, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the second quarter and first half of 2022 on Monday, August 8, 2022, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

Investors interested in listening to the conference call may do so by registering for a unique personal PIN at the following link: https://register.vevent.com/register/BIfc3a52c9352e4e42958e9d816245b3b9. A live and archived webcast of the event will be available on the Company’s investor relations website at https://investors.nyxoah.com/events.

About Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest. 

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:

Nyxoah

Loïc Moreau, Chief Financial Officer

[email protected]

+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications

[email protected]

+1 917 749 1494

Attachment

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Bitcoin falls again, last down 4%
Read More

Bitcoin falls again, last down 4%

Author of the article: Bitcoin dropped again on Saturday and was last down around 4% for the day, hovering around the $35,000 level. Bitcoin, the world’s biggest and best-known cryptocurrency, is now about half its $69,000 peak in November. It was last at $35,049, after falling as low as $34,000 and following a steep fall…
U.S. buys more Stingers after missiles’ success in Ukraine
Read More

U.S. buys more Stingers after missiles’ success in Ukraine

Author of the article: WASHINGTON — The U.S. Army has awarded a contract worth up to $687 million to Raytheon Technologies Corp for anti-aircraft Stinger missiles in order to replenish stocks sent to Ukraine, sources said on Friday. The shoulder-fired anti-aircraft Stinger missiles made by Raytheon were in hot demand in Ukraine, where they have…
France Wants Europe to Cut Its Energy, Raw-Materials Dependence
Read More

France Wants Europe to Cut Its Energy, Raw-Materials Dependence

Author of the article: Bloomberg News John Ainger (Bloomberg) — France wants the European Union to reduce its dependence on countries such as Russia and China for both energy and the raw materials needed to drive the green revolution. The 27-member bloc should ensure it’s not reliant on China when it comes to producing high-tech…
Fed should lift rates a full percentage point by mid-year -Waller
Read More

Fed should lift rates a full percentage point by mid-year -Waller

Author of the article: Federal Reserve Governor Christopher Waller on Thursday laid out the case for a “concerted” effort to rein in inflation, calling for raising interest rates a full percentage point by mid-year, starting with a half-percentage-point hike in March if data in coming weeks continues to point to an “exceedingly hot” economy. “I…